Literature DB >> 15308278

Beta-lactam antibiotics: newer formulations and newer agents.

Stanley I Martin1, Kenneth M Kaye.   

Abstract

beta-Lactam antibiotics share a common structure and mechanism of action, although they differ in their spectrum of antimicrobial activity and utility in treating different infections. The current classes include the penicillins, the penicillinase-resistant penicillins, the extended- spectrum penicillins, the cephalosporins, the carbapenems, and the monobactams. This article discusses some of the newest beta-lactams available for use in the United States: ertapenem, cefditoren, and cefepime. A new formulation of amoxicillin-clavulanate, which contains higher doses of amoxicillin, is also discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308278     DOI: 10.1016/j.idc.2004.04.006

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  3 in total

1.  Cefepime-induced encephalopathy with normal renal function.

Authors:  Andrew Meillier; David Rahimian
Journal:  Oxf Med Case Reports       Date:  2016-06-01

2.  Prevalence and characterization of carbapenem-resistant bacteria in water bodies in the Los Angeles-Southern California area.

Authors:  Dana E Harmon; Osvaldo A Miranda; Ashley McCarley; Michelle Eshaghian; Natasha Carlson; Cristian Ruiz
Journal:  Microbiologyopen       Date:  2018-07-10       Impact factor: 3.139

Review 3.  Antimicrobial resistance mechanisms among Campylobacter.

Authors:  Kinga Wieczorek; Jacek Osek
Journal:  Biomed Res Int       Date:  2013-06-24       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.